Nightingale Health Signs $1M LifeArc Proteomics Agreement
The agreement covers proteomics analysis of 10,000 UK Biobank samples using NULISAseq Neuro 220, with data delivered to UK Biobank. It extends a prior $6.5 million study of 60,000 samples.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The agreement covers proteomics analysis of 10,000 UK Biobank samples using NULISAseq Neuro 220, with data delivered to UK Biobank. It extends a prior $6.5 million study of 60,000 samples.